Aryl Hydrocarbon Receptor

Aryl Hydrocarbon Receptor
Name	Aryl hydrocarbon receptor
Uniprot	P35869

Aryl Hydrocarbon Receptor The Aryl Hydrocarbon Receptor is a ligand-activated transcription factor that mediates cellular responses to a variety of exogenous and endogenous small molecules. Discovered through studies of xenobiotic metabolism, the receptor integrates environmental signals into gene expression programs affecting development, immunity, and metabolism. Research on the receptor intersects with work from laboratories at Max Planck Society, National Institutes of Health, Harvard Medical School, and regulatory findings by United States Environmental Protection Agency and World Health Organization.

Introduction

The receptor was characterized in classical toxicology studies following industrial incidents such as contamination events investigated by teams at Chemical Abstracts Service, U.S. Food and Drug Administration, and academic groups at Stanford University and University of California, Berkeley. Early molecular cloning was achieved by investigators affiliated with Massachusetts Institute of Technology and National Institutes of Health, with subsequent structural studies reported from facilities including European Molecular Biology Laboratory and Rutherford Appleton Laboratory. The receptor links environmental chemistry traced by researchers at DuPont and Dow Chemical Company to cellular transcriptional responses examined in models developed at Cold Spring Harbor Laboratory and Salk Institute.

Structure and Mechanism

The receptor is a basic helix–loop–helix Per-ARNT-Sim (bHLH-PAS) family member structurally related to proteins studied in contexts involving Drosophila melanogaster circadian biology and Neurospora crassa photoreception. High-resolution domain information derives from crystallography groups at European Synchrotron Radiation Facility and cryo-EM work from teams at Weizmann Institute of Science. Mechanistically, cytosolic AHR complexes with chaperones characterized by biochemical studies at The Rockefeller University and Cold Spring Harbor Laboratory, then translocates to the nucleus to dimerize with AHR nuclear translocator (ARNT), a partner also identified in reports from University of Cambridge and University of Oxford. The dimer binds xenobiotic response elements in promoters of genes including CYP1A1, a gene molecularly profiled by research at Johns Hopkins University and Mayo Clinic.

Ligands and Activation

Classical ligands such as 2,3,7,8-tetrachlorodibenzo-p-dioxin were highlighted in regulatory episodes involving Love Canal investigations and assessments by Agency for Toxic Substances and Disease Registry. Other exogenous activators include polycyclic aromatic hydrocarbons evaluated by investigators at Chevron Corporation and combustion studies at Lawrence Berkeley National Laboratory. Endogenous ligands proposed in studies at Karolinska Institutet and University of Tokyo include tryptophan metabolites characterized in metabolomics collaborations with Broad Institute. Pharmaceutical modulation has been pursued by biotech companies including GlaxoSmithKline and Novartis, with clinical implications explored in trials conducted at Mayo Clinic and Cleveland Clinic.

Physiological Roles

Beyond xenobiotic metabolism, receptor functions in immune modulation have been elucidated in work from Pasteur Institute, Imperial College London, and University of Pennsylvania; roles include regulation of T cell subsets identified in studies at Fred Hutchinson Cancer Center and University of California, San Francisco. Developmental roles are supported by genetic models from University of Wisconsin–Madison and University of Michigan. Metabolic implications have been described in collaborations with researchers at University of Cambridge and Yale University, while barrier function and skin biology connections emerged from dermatology groups at Mayo Clinic and King's College London.

Toxicology and Disease Associations

The receptor mediates toxic effects documented in industrial exposures and wartime contamination studies archived by United Nations Environment Programme and International Agency for Research on Cancer. Its activation links to carcinogenesis pathways investigated by teams at National Cancer Institute and epidemiological cohorts run by Framingham Heart Study investigators. Associations with autoimmune and inflammatory disorders were reported by groups at Karolinska Institutet and Johns Hopkins University School of Medicine, while links to metabolic syndrome were examined by researchers at Harvard School of Public Health and University of Oxford. Clinical case series from Centers for Disease Control and Prevention provided public-health perspectives.

Regulation and Signaling Pathways

AHR signaling intersects with pathways involving nuclear receptors documented by work at Scripps Research Institute and transcriptional co-regulators characterized at Stanford University School of Medicine. Crosstalk with hypoxia signaling via ARNT connects to studies by Max Planck Institute for Heart and Lung Research and University of Zurich. Ubiquitin-mediated degradation and feedback loops were elucidated in molecular biology programs at Cold Spring Harbor Laboratory and ETH Zurich. Pharmacologic inhibitors and agonists are being evaluated by industrial research labs at Pfizer and academic translational centers such as Dana-Farber Cancer Institute.

Evolution and Species Differences

Comparative genomics analyses from consortia including Human Genome Project and 1000 Genomes Project revealed conserved and divergent features across vertebrates. Functional divergence between mammalian, avian, and piscine receptors was reported by teams at University of Chicago and University of British Columbia using models such as Mus musculus, Gallus gallus domesticus, and Danio rerio. Evolutionary studies drawing on fossil-calibrated phylogenies by researchers at Smithsonian Institution and Natural History Museum, London have contextualized receptor adaptation to diverse environmental chemical landscapes.

Category:Transcription factors